Tiny URL Website

In studies assessing the efficacy of empagliflozin in bettering glycemic control in sufferers with sort 2 diabetes, a total of 2721 (32%) patients treated with empagliflozin were sixty five years of age and older, and 491 (6%) had been seventy five years of age and older. Gastroin spasm, cardiac les...